CACrown ArchivesThe cinema collection
Menu
Research dossier · General Reference

Ataxia–telangiectasia

a rare, neurodegenerative, autosomal recessive human disease causing severe disability

Cross-disciplinary reference desk with index cards, atlas, dictionary and catalogue
General referenceInterpretive dossier study · Crown Archives visual atlas
Record originEnglish Wikipedia
Text licenseCC BY-SA 4.0
Source revisionAug 17, 2026
Entity authorityQ387082 ↗
Source-derived summary

Ataxia–telangiectasia (AT or A–T), also referred to as ataxia–telangiectasia syndrome or Louis-Bar syndrome, is a rare, neurodegenerative disease causing severe disability. Ataxia refers to poor coordination and telangiectasia to small dilated blood vessels, both of which are hallmarks of the disease. A–T affects many parts of the body:

It impairs certain areas of the brain including the cerebellum, causing difficulty with movement and coordination.

It weakens the immune system, causing a predisposition to infection.

It prevents the repair of broken DNA, increasing the risk of cancer.

Symptoms most often first appear in early childhood (the toddler stage) when children begin to sit or walk. Though they usually start walking at a normal age, they wobble or sway when walking, standing still, or sitting. In late preschool and early school age, they develop difficulty naturally moving their eyes from one place to the next (oculomotor apraxia). They develop slurred or distorted speech and swallowing problems. Some have an increased number of respiratory tract infections (ear infections, sinusitis, bronchitis, and pneumonia).

Editorial summary

This brief starts where responsible research should: with the source description of “Ataxia–telangiectasia” as a rare, neurodegenerative, autosomal recessive human disease causing severe disability. Everything that follows is an evidence route, not borrowed authority.

Editorial reviewA concise reference frame for defining the subject, testing terminology and identifying the institution closest to the evidence. The current 169-word lead offers orientation but no explicit four-digit date, so chronology should not be assumed. The selected authority fields contribute no independent date. The account is most persuasive where Ataxia, telangiectasia and rare can be independently traced.
Editorial analysis

Why this record matters

The subject matters to the general reference register because the source frames it as a rare, neurodegenerative, autosomal recessive human disease causing severe disability. Its deeper value depends on whether names, dates, institutions and citations support that framing.

Evidence profile

Vocabulary and entity names are the principal evidence signals here, because they determine the precision of every later search. The source revision retrieved here is dated Aug 17, 2026. The linked authority identifier is Q387082. None of the 0 selected statements returned an explicit reference.

Critical limits

A concise general-reference account can conceal disagreements about scope, terminology or the weight assigned to individual sources. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.

How to read it

Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.

Best used for
  • Subject orientation
  • Search vocabulary
  • Locating named sources
Verify next

The closest primary source, responsible institution and strongest cited specialist reference.

Three-step research path

  1. Establish the record: confirm the title “Ataxia–telangiectasia”, its source revision and the description used here.
  2. Expand the search: follow Ataxia–telangiectasia primary sources, Ataxia–telangiectasia archive and Ataxia research across catalogues and specialist indexes.
  3. Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.

Questions for further research

  1. Which source most directly establishes the central claim about “Ataxia–telangiectasia”?
  2. Which cited source is closest to the event, object or claim?
  3. What terminology or title could unlock a more precise catalogue search?
Subject index

Search terms from this dossier

Source & attribution

This entry incorporates text from “Ataxia–telangiectasia” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.